BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 34795481)

  • 1. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.
    Alotaibi BS; Buabeid M; Ibrahim NA; Kharaba ZJ; Ijaz M; Noreen S; Murtaza G
    Int J Nanomedicine; 2021; 16():7517-7533. PubMed ID: 34795481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Bhatia R; Sharma A; Narang RK; Rawal RK
    Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
    Jain D; Rashid MA; Ahmad FJ
    Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A
    J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review.
    Hossen S; Hossain MK; Basher MK; Mia MNH; Rahman MT; Uddin MJ
    J Adv Res; 2019 Jan; 15():1-18. PubMed ID: 30581608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles.
    Asl FD; Mousazadeh M; Taji S; Bahmani A; Khashayar P; Azimzadeh M; Mostafavi E
    Nanomedicine (Lond); 2023 Feb; 18(3):279-302. PubMed ID: 37125616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
    Zhang S; Sun J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated nanocarriers: A promising tool for targeted delivery to the brain.
    Gajbhiye KR; Pawar A; Mahadik KR; Gajbhiye V
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110770. PubMed ID: 31926790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
    Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rise of gold nanoparticles as carriers of therapeutic agents.
    Pattnaik S; Thalluri C; Swain K
    Acta Chim Slov; 2023 Nov; 70(4):467-478. PubMed ID: 38124649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
    Shaif M; Kushwaha P; Usmani S; Pandey S
    J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for Delivery of Oligonucleotides to the CNS.
    Male D; Gromnicova R
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.